Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1373 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Microbix forms influenza vaccine subsidiary

Microbix is transferring all of its influenza vaccine assets into Crucible, along with an exclusive worldwide license to its Virusmax technology, and the company’s 50% ownership interest in

FDA accepts QR Pharma bisnorcymserine IND

The compound targets AD via selective butyrylcholinesterase inhibition (BChEI) as well as with a disease modifying activity via amyloid precursor protein (APP) inhibition. QR Pharma has completed all

Momenta Pharma files lawsuit against Teva

The patents cover the Momenta Pharma’s methods of producing Enoxaparin sodium, which assure that the commercial product meets standards for identity and quality. One patent, US Patent no.